ArticleFrontiers in microbiology2026
Viral pathogens in the etiology of acute respiratory infections in Bulgaria during the 2024-2025 season and genetic diversity of circulating influenza viruses.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Respiratory viruses are major contributors to global morbidity and mortality, with influenza viruses having a significant clinical and epidemiological impact. In this study, we examined the virological and epidemiological aspects of influenza infection in comparison with those of other respiratory infections. We further assessed the genetic diversity of circulating influenza viruses and their susceptibility to antivirals. Methods: A total of 2,981 nasopharyngeal specimens from patients with acute respiratory illness were tested for 13 different respiratory viruses using multiplex real-time PCR. Representative influenza strains underwent whole-genome sequencing, phylogenetic and amino acid analyses. Results: At least one respiratory virus was detected in 1,635 (54.8%) patients, and 182 (6.1%) had co-infections involving two to four viruses, including six cases of SARS-CoV-2 and influenza co-infection. Influenza A(H3N2) and B/Victoria lineage viruses predominated, with positivity rates of 12.1 and 10.9%, respectively, followed by rhinoviruses (9.0%), whereas SARS-CoV-2 circulation remained low (3.7%). Influenza infections were most prevalent among children aged 5-14 years. Phylogenetic analysis identified multiple genetic subclades, including C.1.9, C.1.9.1, C.1.9.3, C.1.9.4 and D.5 for A(H1N1)pdm09; J.2, J.2.1, and J.2.2 for A(H3N2), and C.5.1, C.5.6, C.5.6.1, and C.5.7 for B/Victoria lineage. Numerous amino acid substitutions were observed across viral proteins, including within hemagglutinin antigenic sites compared to vaccine strains. Conclusion: The 2024-2025 influenza season in Bulgaria was characterized by high influenza activity and substantial genetic heterogeneity of circulating strains. These findings underline the importance of continuous molecular surveillance to monitor viral evolution, inform vaccine strain selection, and guide national public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.